Observations from GCP Sponsor Inspections
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has observed in various GCP inspections
Operations
Is the GAIN Act Stimulating Antibiotic R&D?
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN Act
The Future of Pfizer’s $5B Brand is in Jeopardy
Maura Musciacco, MSc, Neurology & Ophthalmology Director, GlobalData, assesses what the future holds for Pfizer’s Lyrica
The Top 5: November 2018
CTA highlights the best articles from the month of November 2018
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
Rose Joachim, PhD, Immunology Analyst, GlobalData, examines the impact of newly approved biosimilars on AbbVie’s Humira
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the impact it has on families
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws conclusions
Surveying the Challenges of Preclinical Development
CTA’s Adeola Coker delves into the key issues facing preclinical trials ahead of Arena International’s upcoming Preclinical Development Operations Summit…